|
1
|
Pavri SN, Clune J, Ariyan S and Narayan D:
Malignant melanoma: Beyond the basics. Plast Reconstr Surg.
138:330e–340e. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rastrelli M, Tropea S, Rossi CR and
Alaibac M: Melanoma: Epidemiology, risk factors, pathogenesis,
diagnosis and classification. In Vivo. 28:1005–1011.
2014.PubMed/NCBI
|
|
3
|
Xue YB, Ding MQ, Xue L and Luo JH:
CircAGFG1 sponges miR-203 to promote EMT and metastasis of
non-small-cell lung cancer by upregulating ZNF281 expression.
Thorac Cancer. 10:1692–1701. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao C, Ling X, Li X, Hou X and Zhao D:
MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast
cancer by directly targeting RHBDD1. Breast Cancer. 26:817–825.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ribatti D, Tamma R and Annese T:
Epithelial-mesenchymal transition in cancer: A historical overview.
Transl Oncol. 13:1007732020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Xia H and Yao S: Regulatory T
cells are a double-edged sword in pulmonary fibrosis. Int
Immunopharmacol. 84:1064432020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mansoori B, Mohammadi A, Naghizadeh S,
Gjerstorff M, Shanehbandi D, Shirjang S, Najafi S, Holmskov U,
Khaze V, Duijf PHG and Baradaran B: miR-330 suppresses EMT and
induces apoptosis by downregulating HMGA2 in human colorectal
cancer. J Cell Physiol. 235:920–931. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuki A, Shinkuma S, Hayashi R, Fujikawa H,
Kato T, Homma E, Hamade Y, Onodera O, Matsuoka M, Shimizu H, et al:
CADM1 is a diagnostic marker in early-stage mycosis fungoides:
Multicenter study of 58 cases. J Am Acad Dermatol. 79:1039–1046.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hartsough EJ, Weiss MB, Heilman SA, Purwin
TJ, Kugel CH III, Rosenbaum SR, Erkes DA, Tiago M, HooKim K,
Chervoneva I and Aplin AE: CADM1 is a TWIST1-regulated suppressor
of invasion and survival. Cell Death Dis. 10:2812019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rong G, Zhang M, Xia W, Li D, Miao J and
Wang H: Plasma CADM1 promoter hypermethylation and D-dimer as novel
metastasis predictors of cervical cancer. J Obstet Gynaecol Res.
45:1251–1259. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Qi X, Li Z, Jin S, Xie Y and Zhong
H: lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion
via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag
Res. 11:3813–3828. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
You Y, Zhang J, Li Y, Li Y, Shi G, Ma L
and Wei H: CADM1/TSLC1 inhibits melanoma cell line A375 invasion
through the suppression of matrix metalloproteinases. Mol Med Rep.
10:2621–2626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo J, Jin H, Xi Y, Guo J, Jin Y and Jiang
D: The miR-582/CD1B axis is involved in regulation of dendritic
cells and is associated with clinical outcomes in advanced lung
adenocarcinoma. Biomed Res Int. 2020:43609302020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nayak B, Khan N, Garg H, Rustagi Y, Singh
P, Seth A, Dinda AK and Kaushal S: Role of miRNA-182 and miRNA-187
as potential biomarkers in prostate cancer and its correlation with
the staging of prostate cancer. Int Braz J Urol. 46:614–623. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun X, Xu W, Zang C and Li N:
miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma
via targeting RAB22A. Oncol Lett. 19:771–776. 2020.PubMed/NCBI
|
|
17
|
Tiwari A, Mukherjee B and Dixit M:
MicroRNA key to angiogenesis regulation: MiRNA biology and therapy.
Curr Cancer Drug Targets. 18:266–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen S, Yang C, Sun C, Sun Y, Yang Z,
Cheng S and Zhuge B: miR-21-5p suppressed the sensitivity of
hepatocellular carcinoma cells to cisplatin by targeting FASLG. DNA
Cell Biol. 38:865–873. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo HL, Chen LD, Li W, Liang JY, Zhang JC,
Li X, Xie XY, Lu MD, Kuang M and Wang W: Ultrasomics for early
evaluation of the tumor response to microRNA-122 in a nude mouse
hepatocellular carcinoma model. J Ultrasound Med. 39:61–71. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin T, Hou PF, Meng S, Chen F, Jiang T, Li
ML, Shi ML, Liu JJ, Zheng JN and Bai J: Emerging roles of p53
related lncRNAs in cancer progression: A systematic review. Int J
Biol Sci. 15:1287–1298. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Zhuang W, Wang Z, Xiao W, Don W,
Li X and Chen X: MicroRNA-450b-3p inhibits cell growth by targeting
phosphoglycerate kinase 1 in hepatocellular carcinoma. J Cell
Biochem. 120:18805–18815. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen J, Lin Y, Jia Y, Xu T, Wu F and Jin
Y: LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer
via restoration of BCL2L11 as a sponge of microRNA-340-5p. J Cell
Physiol. 234:23421–23436. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li
J, Wang Z, Chen X, Zhang W, Yokoyama S, et al: Tumor-secreted
miR-214 induces regulatory T cells: A major link between immune
evasion and tumor growth. Cell Res. 24:1164–1180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mirzaei H, Gholamin S, Shahidsales S,
Sahebkar A, Jaafari MR, Mirzaei HR, Hassanian SM and Avan A:
MicroRNAs as potential diagnostic and prognostic biomarkers in
melanoma. Eur J Cancer. 53:25–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Uketa S, Shimizu Y, Ogawa K, Utsunomiya N,
Katsushima H, Ishihara M, Hashimoto K and Kanamaru S: A case of
isolated peritoneal metastasis from prostate cancer. Hinyokika
Kiyo. 65:175–179. 2019.(In Japanese). PubMed/NCBI
|
|
28
|
Shi J, Lu P, Shen W, He R, Yang MW, Fang
Y, Sun YW, Niu N and Xue J: CD90 highly expressed population
harbors a stemness signature and creates an immunosuppressive niche
in pancreatic cancer. Cancer Lett. 453:158–169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakano K, Masui T, Yogo A, Uchida Y, Sato
A, Kasai Y, Nagai K, Anazawa T, Kawaguchi Y and Uemoto S:
Chloroquine induces apoptosis in PanNEN via endoplasmic reticulum
stress. Endocr Relat Cancer. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen C, Hua H, Gu L, Cao S, Cai H, Yao X
and Chen X: miR-124 functions as a melanoma tumor suppressor by
targeting RACK1. Onco Targets Ther. 12:9975–9986. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chockley PJ, Chen J, Chen G, Beer DG,
Standiford TJ and Keshamouni VG: Epithelial-mesenchymal transition
leads to NK cell-mediated metastasis-specific immunosurveillance in
lung cancer. J Clin Invest. 128:1384–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Slaney CY, Rautela J and Parker BS: The
emerging role of immunosurveillance in dictating metastatic spread
in breast cancer. Cancer Res. 73:5852–5857. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hong H, Gu Y, Zhang H, Simon AK, Chen X,
Wu C, Xu XN and Jiang S: Depletion of CD4+CD25+ regulatory T cells
enhances natural killer T cell-mediated anti-tumour immunity in a
murine mammary breast cancer model. Clin Exp Immunol. 159:93–99.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Olkhanud PB, Baatar D, Bodogai M, Hakim F,
Gress R, Anderson RL, Deng J, Xu M, Briest S and Biragyn A: Breast
cancer lung metastasis requires expression of chemokine receptor
CCR4 and regulatory T cells. Cancer Res. 69:5996–6004. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paolino M, Choidas A, Wallner S, Pranjic
B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa
JP, et al: The E3 ligase Cbl-b and TAM receptors regulate cancer
metastasis via natural killer cells. Nature. 507:508–512. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang L, Huang J, Ren X, Gorska AE, Chytil
A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC and Moses
HL: Abrogation of TGF beta signaling in mammary carcinomas recruits
Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell.
13:23–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei CY, Zhu MX, Yang YW, Zhang PF, Yang X,
Peng R, Gao C, Lu JC, Wang L, Deng XY, et al: Downregulation of
RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and
stemness via CD44 and CTTN ubiquitination in melanoma. J Hematol
Oncol. 12:212019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pearlman RL, Montes de Oca MK, Pal HC and
Afaq F: Potential therapeutic targets of epithelial-mesenchymal
transition in melanoma. Cancer Lett. 391:125–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang C, Li K, Men Y, Ding C, Du J, Liang
T, Ji Z, Chen L, Wang T and Kang Q: Protein 4.1B suppresses tumor
metastasis by regulating epithelial-mesenchymal transition
progression in melanoma cells. Int J Med Sci. 16:529–536. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wels C, Joshi S, Koefinger P, Bergler H
and Schaider H: Transcriptional activation of ZEB1 by Slug leads to
cooperative regulation of the epithelial-mesenchymal
transition-like phenotype in melanoma. J Invest Dermatol.
131:1877–1885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bie Y, Ge W, Yang Z, Cheng X, Zhao Z, Li
S, Wang W, Wang Y, Zhao X, Yin Z and Li Y: The crucial role of
CXCL8 and its receptors in colorectal liver metastasis. Dis
Markers. 2019:80234602019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Penna E, Orso F, Cimino D, Vercellino I,
Grassi E, Quaglino E, Turco E and Taverna D: miR-214 coordinates
melanoma progression by upregulating ALCAM through TFAP2 and
miR-148b downmodulation. Cancer Res. 73:4098–4111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maity S, Das F, Ghosh-Choudhury N,
Kasinath BS and Ghosh Choudhury G: High glucose increases miR-214
to power a feedback loop involving PTEN and the Akt/mTORC1
signaling axis. FEBS Lett. 593:2261–2272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gong L, Xu H, Zhang X, Zhang T, Shi J and
Chang H: Oridonin relieves hypoxia-evoked apoptosis and autophagy
via modulating microRNA-214 in H9c2 cells. Artif Cells Nanomed
Biotechnol. 47:2585–2592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Eguchi S, Takefuji M, Sakaguchi T,
Ishihama S, Mori Y, Tsuda T, Takikawa T, Yoshida T, Ohashi K,
Shimizu Y, et al: Cardiomyocytes capture stem cell-derived,
anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in
acute myocardial infarction. J Biol Chem. 294:11665–11674. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun R, Liu Z, Han L, Yang Y, Wu F, Jiang
Q, Zhang H, Ma R, Miao J, He K, et al: miR-22 and miR-214 targeting
BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal
transition by down-regulating Wnt signaling in colon cancer. FASEB
J. 33:5411–5424. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Okazaki Y, Chew SH, Nagai H, Yamashita Y,
Ohara H, Jiang L, Akatsuka S, Takahashi T and Toyokuni S:
Overexpression of miR-199/214 is a distinctive feature of iron- and
asbestos-induced sarcomatoid mesothelioma in rats. Cancer Sci.
2020.(Epub ahead of print). View Article : Google Scholar
|
|
48
|
Kong L, Liu P, Zheng M, Wang Z, Gao Y,
Liang K, Wang H and Tan X: The miR-1224-5p/ELF3 axis regulates
malignant behaviors of pancreatic cancer via PI3K/AKT/Notch
signaling pathways. Onco Targets Ther. 13:3449–3466. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Duan Y, Tan Z, Yang M, Li J, Liu C, Wang
C, Zhang F, Jin Y, Wang Y and Zhu L: PC-3-derived exosomes inhibit
osteoclast differentiation by downregulating miR-214 and blocking
NF-κB signaling pathway. Biomed Res Int. 2019:86508462019.
View Article : Google Scholar : PubMed/NCBI
|
